Product Information
GS HEMORRHOIDAL SUPPOSITORIES is a generic product labeled by L. Perrigo Company, priced at $0.2881 per EA under NDC 00113027953. Its NADAC has been published 563 times since Dec 23, 2015.
Strength
2211; 6.5 mg/1; mg/1
Manufacturer
L. Perrigo CompanyNDC
00113027953
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M015On Market Since
9/4/2014
Pharmacological Classes
Price Statistics
The NADAC for GS HEMORRHOIDAL SUPPOSITORIES has been published 563 times since Dec 23, 2015, and over the history we have for it it has risen 44.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2881 per EA |
|---|---|
| All-time high | $0.2970 (Sep 16, 2026) |
| All-time low | $0.1695 (Apr 19, 2023) |
| 52-week high | $0.2970 |
| 52-week low | $0.2393 |
| Median price | $0.1979 |
| Average price | $0.2017 |
| Largest weekly change | +23.8% (May 17, 2023) |
| Weeks tracked | 563 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cocoa butter, phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS HEMORRHOIDAL SUPPOSITORIES?
The current National Average Drug Acquisition Cost (NADAC) for GS HEMORRHOIDAL SUPPOSITORIES, manufactured by L. Perrigo Company, is $0.2881 per EA (NDC 00113027953), effective Sep 30, 2026.
How has the price of GS HEMORRHOIDAL SUPPOSITORIES changed over time?
Over the history we have for it, the NADAC for GS HEMORRHOIDAL SUPPOSITORIES has risen 44.3%. It has been tracked across 563 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for GS HEMORRHOIDAL SUPPOSITORIES?
Since Dec 23, 2015, the NADAC for GS HEMORRHOIDAL SUPPOSITORIES has ranged from a low of $0.1695 (Apr 19, 2023) to a high of $0.2970 (Sep 16, 2026), with a median of $0.1979 per EA.
Are there cheaper alternatives to GS HEMORRHOIDAL SUPPOSITORIES?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HEMORRHOIDAL SUPPOSITORIES, is $0.1840 per EA — about 36% below GS HEMORRHOIDAL SUPPOSITORIES.
Who manufactures GS HEMORRHOIDAL SUPPOSITORIES?
GS HEMORRHOIDAL SUPPOSITORIES (NDC 00113027953) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.